Tychobio.ai chooses The HIVE Innovation Center to Accelerate the Development of its RNA Therapy Design Technologies
Villejuif, 28/04/2026 – Kadans Science Partner announces that Tychobio, a biotech start-up specialising in AI-assisted RNA therapy design, has taken up residence at The HIVE Innovation Center, a laboratory and office building dedicated to life sciences, located on the Campus Grand Parc in Villejuif.
A Key Player in Computational Biology
Tychobio is developing a platform that combines high-throughput screening and machine learning, integrated within a lab-in-the-loop approach to accelerate and enhance the design of RNA therapies and the modulation of RNA regulatory mechanisms. TychoBio’s models enable the design of safe and effective therapies, addressing both ultra-rare diseases and more common conditions.
The HIVE Innovation Centre: An Agile Environment Designed for Scaling Biotechs
Designed to meet the specific needs of life sciences start-ups, The HIVE offers a fully integrated and immediately operational environment: ready-to-use laboratories, modular office spaces, shared equipment, and flexible services designed to support day-to-day R&D operations. This setting provides growing companies with optimal conditions to structure their activities, accelerate development and interact with leading scientific and industrial stakeholders, within an ecosystem strongly driven by the momentum of the Paris-Saclay Cancer Cluster (PSCC).
A Strategic Location at the Heart of Campus Grand Parc
Located to the south of Paris, Campus Grand Parc is a major hub for oncology, biotechnology and healthcare innovation, in which the Paris-Saclay Cancer Cluster (PSCC) plays a structuring role. It brings together research institutes, university hospitals, academic laboratories and deeptech companies, forming a unique ecosystem that fosters collaboration and translational research. For Tychobio, this move represents a decisive opportunity to strengthen partnerships and accelerate the practical application of its technologies.
“The HIVE Innovation Centre provides us with the ideal framework to rapidly set up our laboratories and quickly scale up our data generation platform, within a stimulating environment offering numerous opportunities for industrial and academic collaboration,” explains Mathurin Dorel, Chief Scientific Officer at Tychobio.ai.
“The arrival of Tychobio at The HIVE Innovation Centre illustrates our commitment to supporting innovative and ambitious projects,” says Sandrine Lo, Investment & Asset Manager at Kadans Science Partner.
More info about the Innovation Center
More info about Campus Grand Parc
